Money Talks News on MSN
Testing for Alzheimer's disease could soon be a finger prick away, thanks to a revolutionary breakthrough
A new blood test could replace the brain scans and spinal taps currently used to diagnose Alzheimer's disease.
The dedicated billing code, 0640U, effective July 1, 2026, establishes a unique reimbursement identifier for the CNSide CSF TCE test, supporting payer claims processing and facilitating broader ...
Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system ...
CNSide Diagnostics, LLC, a wholly-owned subsidiary of Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), today announces a new payer coverage agreement with Highmark, effective April 1, ...
More than 7 million Americans live with Alzheimer's disease, with health and long-term care costs for AD and other forms of dementia were projected to reach nearly $400 billion in 2025.
Diagnosing brain diseases such as Parkinson’s disease and dementia can be very difficult, especially in the early stages. Many of these conditions share similar symptoms, including memory loss, ...
A new study from the University of California, San Diego, suggests a simple blood test could help predict dementia decades before symptoms appear. Researchers analyzed blood samples from more than ...
A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.
A simple blood test could predict not only a person’s risk of developing Alzheimer’s disease, but also the year symptoms will begin. Researchers at the Washington University School of Medicine in St.
Researchers report that a spinal fluid test can be 100 percent accurate in identifying patients with significant memory loss who are on their way to developing Alzheimer's disease. Although there has ...
THE U.S. IS in a dementia crisis. According to a recent study published in Nature Medicine, by 2060, diagnoses of cognitive decline are expected to hit a rate of 1 million a year—double what they were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results